PharmaShots | Incisive News in 3 Shots

Subscribe Now

Filing

Moderna to Seek the FDA and EMA's EUA for mRNA-1273 and Shows 100% Efficacy in P-III COVE-Study

Moderna to Seek the FDA and EMA's EUA for mRNA-1273 and Shows 100% Efficacy in P-III COVE-Study

December 1, 2020

Genmab's Darzalex (daratumumab) + Bortezomib + Thalidomide and Dexamethasone (VTd) Receive FDA's Priority Review to sBLA Filing for Frontline Multiple Myeloma

Genmab's Darzalex (daratumumab) + Bortezomib + Thalidomide and Dexamethasone (VTd) Receive FDA's Priority Review to sBLA Filing fo...

May 31, 2019

Janssen (J&J) Reports Filing of Stelara's (ustekinumab) in Group Type II Variation Application to EMA for Moderately to Severely Active Ulcerative Colitis (UC)

Janssen (J&J) Reports Filing of Stelara's (ustekinumab) in Group Type II Variation Application to EMA for Moderately to Severe...

January 9, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us